All articles by Salong Debbarma

Salong Debbarma

Memphasys and Monash IVF sign national supply deal for Felix system

Australian-based Memphasys and Monash IVF Group have finalised a 12-month exclusive national supply agreement for the Felix automated sperm selection…
Distalmotion secures second FDA gynaecology clearance for DEXTER system

Swiss medical device company Distalmotion has secured the US Food and Drug Administration (FDA) 510(k) clearance for its DEXTER robotic…
Raydiant concludes enrolment in pilot study at LSUHS

Raydiant Oximetry has completed enrolment and data collection for the initial 15 patients in its pilot study at Louisiana State…
FDA approves Bayer’s Ambelvist contrast agent

The US Food and Drug Administration (FDA) has approved Bayer’s Ambelvist (gadoquatrane), a macrocyclic gadolinium-based contrast agent (mGBCA), for use…
Dimora Medical introduces MegaSorb technology for advanced wound care

Dimora Medical has launched MegaSorb technology, designed for use in silicone foam dressings. The company announced the development as demand…

Fleming Initiative and Cepheid begin TRACE-CPE study on rapid CPE testing

The Fleming Initiative, a partnership between Imperial College London and Imperial College Healthcare National Health Service (NHS) Trust, and Cepheid,…
FDA clears Alpha Tau to advance REGAIN trial enrolment

Alpha Tau Medical has received clearance from the US Food and Drug Administration (FDA) to proceed with enrolment of the…
First patient treated in Airiver Medical’s RESTORE-2 trial for CRS

Airiver Medical has treated the first patient in its RESTORE-2 pivotal clinical trial assessing the ESSpand Sinus drug-coated balloon (DCB)…
FDA clears KARL STORZ’s RUBINA Lens for use in open surgery

KARL STORZ has received clearance from the US Food and Drug Administration (FDA) for its RUBINA Lens exoscope, authorising its…
Sibel Health’s ANNE One platform secures EU MDR CE mark

Sibel Health has received CE mark certification under the EU Medical Device Regulation (EU MDR 2017/745) for its ANNE One…